Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Guglielmi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2006
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastasesAhmed Boucharaba, Claire-Marie Serre, Julien Guglielmi, et al.
Cancer Research|November 20, 2002
Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated ratsPierrick Fournier, Sandrine Boissier, Stéphanie Filleur, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|May 11, 2016
High-Frequency Quantitative Ultrasound Spectroscopy of Excised Canine Livers and Mouse Tumors Using the Structure Factor ModelPauline Muleki-Seya, Regine Guillermin, Julien Guglielmi, et al.
Thyroid : Official Journal of the American Thyroid Association|April 14, 2010
Distribution and dynamics of (99m)Tc-pertechnetate uptake in the thyroid and other organs assessed by single-photon emission computed tomography in living micePhilippe R Franken, Julien Guglielmi, Christian Vanhove, et al.
Journal of Clinical Medicine|January 26, 2020
Proteomic Analysis of Iodinated Contrast Agent-Induced Perturbation of Thyroid Iodide UptakeMaha Hichri, Georges Vassaux, Jean-Marie Guigonis, et al.
International Journal of Cancer|April 20, 2005
Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivoAurélie Fontana, Stéphanie Filleur, Julien Guglielmi, et al.
Cancer Research|July 23, 2003
SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growthStéphanie Filleur, Aurélie Courtin, Slimane Ait-Si-Ali, et al.
The Journal of Clinical Investigation|December 16, 2004
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancerAhmed Boucharaba, Claire-Marie Serre, Sandra Grès, et al.
Thyroid : Official Journal of the American Thyroid Association|June 29, 2016
Single-Photon Emission Computed Tomography for Preclinical Assessment of Thyroid Radioiodide Uptake Following Various Combinations of Preparative MeasuresColette Zwarthoed, Kaouthar Chatti, Julien Guglielmi, et al.
Cancer Research|January 25, 2005
Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostateMarc Colombel, Stéphanie Filleur, Pierick Fournier, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2006
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastasesAhmed Boucharaba, Claire-Marie Serre, Julien Guglielmi, et al.
Cancer Research|November 20, 2002
Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated ratsPierrick Fournier, Sandrine Boissier, Stéphanie Filleur, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|May 11, 2016
High-Frequency Quantitative Ultrasound Spectroscopy of Excised Canine Livers and Mouse Tumors Using the Structure Factor ModelPauline Muleki-Seya, Regine Guillermin, Julien Guglielmi, et al.
Thyroid : Official Journal of the American Thyroid Association|April 14, 2010
Distribution and dynamics of (99m)Tc-pertechnetate uptake in the thyroid and other organs assessed by single-photon emission computed tomography in living micePhilippe R Franken, Julien Guglielmi, Christian Vanhove, et al.
Journal of Clinical Medicine|January 26, 2020
Proteomic Analysis of Iodinated Contrast Agent-Induced Perturbation of Thyroid Iodide UptakeMaha Hichri, Georges Vassaux, Jean-Marie Guigonis, et al.
International Journal of Cancer|April 20, 2005
Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivoAurélie Fontana, Stéphanie Filleur, Julien Guglielmi, et al.
Cancer Research|July 23, 2003
SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growthStéphanie Filleur, Aurélie Courtin, Slimane Ait-Si-Ali, et al.
The Journal of Clinical Investigation|December 16, 2004
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancerAhmed Boucharaba, Claire-Marie Serre, Sandra Grès, et al.
Thyroid : Official Journal of the American Thyroid Association|June 29, 2016
Single-Photon Emission Computed Tomography for Preclinical Assessment of Thyroid Radioiodide Uptake Following Various Combinations of Preparative MeasuresColette Zwarthoed, Kaouthar Chatti, Julien Guglielmi, et al.
Cancer Research|January 25, 2005
Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostateMarc Colombel, Stéphanie Filleur, Pierick Fournier, et al.
Pageof 3